(Q42704420)

5 November 2017

0 references

1 reference

title

Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists (English)

1 reference

5 November 2017

1 reference

1 reference

Raúl-J Andrade

1

1 reference

5 November 2017

Mercedes Robles

2

1 reference

5 November 2017

Alejandra Fernández-Castañer

3

1 reference

5 November 2017

Susana López-Ortega

4

1 reference

5 November 2017

M-Carmen López-Vega

5

1 reference

5 November 2017

M-Isabel Lucena

6

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

World Journal of Gastroenterology

5 November 2017

1 reference

5 November 2017

13

1 reference

5 November 2017

329-340

1 reference

5 November 2017

3

1 reference

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Outcome and prognostic markers in severe drug-induced liver disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Recognizing drug-induced liver injury: current problems, possible solutions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Causality assessment in drug-induced hepatotoxicity.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Acute Liver Failure in the United States

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced hepatotoxicity.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Hepatotoxicity of antimicrobial agents

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced liver disorders: implications for drug development and regulation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced liver diseases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Fatal hepatitis and renal failure during treatment with nimesulide

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Trovafloxacin-induced acute hepatitis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Accuracy of hepatic adverse drug reaction reporting in one English health region

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

The natural history of histologically proved drug induced liver disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Cirrhosis with steatohepatitis after adjuvant tamoxifen

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Nimesulide-induced acute hepatitis: evidence from six cases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Morphologic spectrum of drug-induced hepatic disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Bentazepam-associated chronic liver disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

A method for estimating the probability of adverse drug reactions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Computerized comparison of six adverse drug reaction assessment procedures

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Hepatotoxic effects of the anabolic/androgenic steroids

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Methotrexate-induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA-related matters. American College of Gastroenterology

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Criteria of drug-induced liver disorders. Report of an international consensus meeting

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced liver injury: summary of a single topic clinical research conference

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Benzylpenicillin-induced prolonged cholestasis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Drug-induced liver injury: mechanisms and test systems.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Fatal hepatitis associated with nimesulide.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

A Bayesian neural network method for adverse drug reaction signal generation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065885

Acute liver failure after treatment with nefazodone

16 August 2018

1 reference

12 December 2020

Celecoxib-induced acute pancreatitis and hepatitis: a case report

1 reference

12 December 2020

Comparison of two clinical scales for causality assessment in hepatotoxicity

1 reference

12 December 2020

Causality assessment versus guilt-by-association in drug hepatotoxicity

1 reference

12 December 2020

[Drug-induced hepatotoxicity. The 13th updated edition of the bibliographic database of drug-related liver injuries and responsible drugs]

1 reference

12 December 2020

Assessing causality in drug-induced liver injury

1 reference

12 December 2020

Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin/clavulanic acid

1 reference

12 December 2020

Liver biopsy in elevated liver functions tests? An old question revisited

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced cholestasis

1 reference

12 December 2020

Medical Mystery — The Answer

1 reference

12 December 2020

Drug-induced liver injury

1 reference

12 December 2020

Is the Naranjo Probability Scale Accurate Enough to Ascertain Causality in Drug-Induced Hepatotoxicity?

1 reference

12 December 2020

Drug-induced liver injury network (DILIN)

1 reference

12 December 2020

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

12 December 2020

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

1 reference

12 December 2020

Assessing methods for causality assessment of suspected adverse drug reactions

1 reference

12 December 2020

Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients

1 reference

12 December 2020

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge

1 reference

12 December 2020

The lymphocyte transformation test--a debated method for the evaluation of drug allergic hepatic injury

1 reference

12 December 2020

Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective

1 reference

12 December 2020

[Cholestatic hepatitis caused by midecamycin]

1 reference

12 December 2020

Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis

1 reference

12 December 2020

Immunological investigation in hepatic drug reactions

1 reference

12 December 2020

Severe hepatotoxicity associated with troglitazone

1 reference

12 December 2020

Minocycline and Lupuslike Syndrome in Acne Patients

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V13.I3.329

1 reference

5 November 2017

1 reference

5 November 2017

1 reference